Macrophage activation switching: an asset for the resolution of inflammation
暂无分享,去创建一个
D. Dormont | G. Gras | N. Dereuddre-Bosquet | F. Porcheray | S. Viaud | A.‐C. Rimaniol | C. Léone | B. Samah | N. Dereuddre‐Bosquet | D. Dormont | G. Gras | S. Viaud | A. Rimaniol | F. Porcheray | B. Samah | C. Léone
[1] D. Langer,et al. Phenotypic characterization of macrophages in human term placenta. , 1989, Immunology.
[2] D. Schaer,et al. Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteine-rich family , 2001, Immunogenetics.
[3] D. Vaux,et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. , 1999, Journal of immunology.
[4] D. Schaer,et al. Induction of the CD163‐dependent haemoglobin uptake by macrophages as a novel anti‐inflammatory action of glucocorticoids , 2002, British journal of haematology.
[5] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[6] R. Beelen,et al. Regulation of CD163 on human macrophages: cross‐linking of CD163 induces signaling and activation , 1999, Journal of leukocyte biology.
[7] Y. Sakaki,et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.
[8] S. Goerdt,et al. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[9] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[10] S. Goerdt,et al. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9−) in psoriatic dermis , 1996, Archives of Dermatological Research.
[11] D. Lange,et al. Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. , 1989, Journal of periodontal research.
[12] M. McGrath,et al. Balanced Macrophage Activation Hypothesis: A Biological Model for Development of Drugs Targeted at Macrophage Functional States , 2000, Pathobiology.
[13] C. Figdor,et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. , 1993, Journal of immunology.
[14] M. Miyazaki,et al. CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1 , 2004, The Journal of Immunology.
[15] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[16] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[17] J. Suttles,et al. Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.
[18] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[19] J C Gluckman,et al. Dendritic cells as the terminal stage of monocyte differentiation. , 1998, Journal of immunology.
[20] V. Fadok,et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.
[21] S. Goerdt,et al. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. , 1993, The American journal of pathology.
[22] P. Högger,et al. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). , 1998, Journal of immunology.
[23] S. Moestrup,et al. Identification of the haemoglobin scavenger receptor , 2001, Nature.
[24] P. Wallace,et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. , 2000, Cytokine.
[25] A. Rees,et al. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. , 1998, Journal of immunology.
[26] T. Langmann,et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.
[27] T. Mcclanahan,et al. A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.
[28] Timothy Ravasi,et al. The mononuclear phagocyte system revisited , 2002, Journal of leukocyte biology.